Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what estimate he has made of the (a) forecast reduction in cases of and deaths from infection by Group C meningococcal disease as a result of the introduction of the meningitis C vaccine to the UK schedule in 1999, (b) number of meningitis C vaccinations administered in each year since that programme began and (c) cost of delivering that programme in each year since 1999.

Deaths have fallen from 110 in 1998/99 to an annual average of 3 deaths over the last 10 years. Annual MenC cases and deaths have therefore been respectively 97% and 96% lower in the last 10 years than in the year before vaccination was available.

Routine immunisation programmes with MenC containing vaccines have changed since 1999 and this has affected the ability to collect estimate annual numbers of doses administered for each vaccine offered but currently around 96% of infants receive MenC vaccine and 93% of one year olds receive their MenC-Hib booster in England by their second birthday. Coverage data are not routinely collected on the third dose in adolescence (currently MenACWY vaccine) which began in the 2013-2014 school year.

The administrative costs for the MenC programme are included in the global sum payment to general practitioners (managed by NHS England) which covers the costs of providing essential and additional primary care services.